Increased Mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery

Circulation

Volumn 117, Issue 25, 2008, Pages

  Augoustides, John G T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

DATA ANALYSIS; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEART SURGERY; LETTER; MARKET; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ECONOMICS; EPIDEMIOLOGY; FACTUAL DATABASE; HEART DISEASE; HUMAN; MULTICENTER STUDY; NOTE; UNITED KINGDOM;

APROTININ; CARDIAC SURGICAL PROCEDURES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; GREAT BRITAIN; HEART DISEASES; HUMANS; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE PERIOD;

EID: 51649113177     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.760843     Document Type: Letter

References (3)

1. Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116: 2544-2552.
2. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353-365.
3. Trasylol Home Page. http://www.trasylol.com. Accessed December 12, 2007.